CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results

BACKGROUND: Patients with refractory/relapsed (r/r) acute B lymphocytic leukemia (B-ALL) can achieve complete response (CR) after chimeric antigen receptor T-cell (CAR-T) therapy, but recurrence occurs in the short term. To reduce recurrence and improve survival, CAR-T therapy followed by transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhihui, Yang, Keyan, Song, Yanzhi, Zhao, Yongqiang, Wu, Fan, Wen, Xiaopei, Li, Jing, Wang, Xianxuan, Xu, Teng, Zheng, Xiaoyu, Zheng, Qinglong, Wu, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846489/
https://www.ncbi.nlm.nih.gov/pubmed/36686744
http://dx.doi.org/10.3389/fonc.2022.1048296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846489/
https://www.ncbi.nlm.nih.gov/pubmed/36686744
http://dx.doi.org/10.3389/fonc.2022.1048296

Ejemplares similares